ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 248

$641K Total Retail Price of All Prescriptions

Rank: 5 out of 248

946 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 946 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

5% of this provider’s 946 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 10,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 6.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
CARVEDILOL 770 640 1 17
METOPROLOL SUCCINATE 693 543 2 19
LISINOPRIL 542 421 3 2
AMLODIPINE BESYLATE 535 466 4 4
WARFARIN SODIUM 534 375 5 15
FUROSEMIDE 456 366 6 8
SIMVASTATIN 451 395 7 3
PRAVASTATIN SODIUM 357 259 8 16
ATORVASTATIN CALCIUM 313 271 9 22
LEVOTHYROXINE SODIUM 312 223 10 6
OMEPRAZOLE 295 254 11 5
CLOPIDOGREL 286 216 12 32
LOSARTAN POTASSIUM 254 236 13 27
METOPROLOL TARTRATE 228 185 14 12
ISOSORBIDE MONONITRATE ER 208 154 15 53
CRESTOR 200 142 16 33
PLAVIX 199 158 17 64
METFORMIN HCL 195 151 18 9
HYDROCHLOROTHIAZIDE 149 129 19 10
ATENOLOL 148 127 20 26
SPIRONOLACTONE 148 115 20 91
NIASPAN 148 113 20 92
DIGOXIN 136 122 23 114
ZETIA 126 101 24 98
HYDRALAZINE HCL 123 113 25 104
TRAMADOL HCL 121 86 26 14
HYDROCODONE-ACETAMINOPHEN 121 103 S3 26 1
BUMETANIDE 118 93 28 123
GLIPIZIDE 114 92 29 84
BYSTOLIC 113 69 30 127
PANTOPRAZOLE SODIUM 110 80 31 85
RANEXA 109 95 32 131
POTASSIUM CHLORIDE 100 80 33 29
ENALAPRIL MALEATE 88 58 34 74
NEXIUM 85 72 35 39
DILTIAZEM 24HR CD 85 72 35 141
KLOR-CON M20 76 40 37 149
RAMIPRIL 74 55 38 151
RANITIDINE HCL 73 69 39 45
TRICOR 72 34 40 154
NITROSTAT 72 60 40 117
LOVASTATIN 72 51 40 44
WELCHOL 66 43 43 161
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 49 44 38
DILTIAZEM 24HR ER 63 53 45 165
MELOXICAM 62 50 46 37
LOSARTAN-HYDROCHLOROTHIAZIDE 60 59 47 79
DIOVAN 57 57 48 107
CITALOPRAM HBR 57 53 48 28
GABAPENTIN 56 43 50 11
AMITRIPTYLINE HCL 53 42 R 51 108
PROAIR HFA 53 40 51 65
SINGULAIR 53 41 51 126
TRILIPIX 52 0 54 193
TRAZODONE HCL 51 18 55 24
TAMSULOSIN HCL 51 43 55 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.